Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Introduction: anti-IgE

Bruce Bochner1, Sarbjit Saini

  • 1Division of Allergy and Clinical Immunology, Johns Hopkins Asthma and Allergy Center, USA.

Clinical Reviews in Allergy & Immunology
|October 14, 2005
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Remibrutinib impact on disease control, sleep, and quality of life: Analysis of phase 3 REMIX-1/2.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2026
Same author

Safety of remibrutinib in chronic spontaneous urticaria: a pooled analysis of REMIX-1 and REMIX-2 trials.

The journal of allergy and clinical immunology. In practice·2026
Same author

Long-Term Efficacy and Safety of Ligelizumab as Re-Treatment in Patients With Chronic Spontaneous Urticaria.

Allergy·2025
Same author

Biopredictors for Omalizumab Response in Patients With Chronic Spontaneous Urticaria.

The journal of allergy and clinical immunology. In practice·2025
Same author

Remibrutinib in chronic spontaneous urticaria: 52-week results from two phase 3 studies.

The Journal of allergy and clinical immunology·2025
Same author

Remibrutinib in Chronic Spontaneous Urticaria.

The New England journal of medicine·2025